Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Gray

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
JACC. Cardiovascular Imaging|March 20, 2026
Biological, Radiological, and Clinical Significance of Spotty Calcification in Coronary Artery Disease: A State-of-the-Art ReviewSina Fathieh, Michael P Gray, Max Kirkby, et al.
American Heart Journal|June 26, 2023
Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trialMichael P Gray, Yemima Berman, Giordano Bottà, et al.
BMJ Open|September 30, 2021
Protocol for the Stimulating β<sub>3</sub>-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial diseaseKristen J Bubb, Jason A Harmer, Meghan Finemore, et al.
Biomolecules|June 28, 2023
Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery CohortDantong Zhu, Stephen T Vernon, Zac D'Agostino, et al.
American Journal of Preventive Cardiology|June 3, 2024
Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease - A system dynamics modelStephen T Vernon, Stuart Brentnall, Danielle J Currie, et al.
The European Respiratory Journal|November 27, 2020
EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHARMarissa Borgese, David Badesch, Todd Bull, et al.
Analytical Chemistry|March 27, 2026
A Clinical Lipidomics Platform: Development and Validation of a High-Throughput LC-MS Assay for Cardiovascular Disease Risk AssessmentThomas G Meikle, Jingqin Wu, Tingting Wang, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2018
Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium ReportJason M Elinoff, Richa Agarwal, Christopher F Barnett, et al.
Journal of the American College of Cardiology|July 24, 2024
Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary PreventionJingqin Wu, Corey Giles, Aleksandar Dakic, et al.
Circulation Research|October 28, 2017
PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through PhenomicsAnna R Hemnes, Gerald J Beck, John H Newman, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
JACC. Cardiovascular Imaging|March 20, 2026
Biological, Radiological, and Clinical Significance of Spotty Calcification in Coronary Artery Disease: A State-of-the-Art ReviewSina Fathieh, Michael P Gray, Max Kirkby, et al.
American Heart Journal|June 26, 2023
Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trialMichael P Gray, Yemima Berman, Giordano Bottà, et al.
BMJ Open|September 30, 2021
Protocol for the Stimulating β<sub>3</sub>-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial diseaseKristen J Bubb, Jason A Harmer, Meghan Finemore, et al.
Biomolecules|June 28, 2023
Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery CohortDantong Zhu, Stephen T Vernon, Zac D'Agostino, et al.
American Journal of Preventive Cardiology|June 3, 2024
Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease - A system dynamics modelStephen T Vernon, Stuart Brentnall, Danielle J Currie, et al.
The European Respiratory Journal|November 27, 2020
EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHARMarissa Borgese, David Badesch, Todd Bull, et al.
Analytical Chemistry|March 27, 2026
A Clinical Lipidomics Platform: Development and Validation of a High-Throughput LC-MS Assay for Cardiovascular Disease Risk AssessmentThomas G Meikle, Jingqin Wu, Tingting Wang, et al.
American Journal of Respiratory and Critical Care Medicine|February 10, 2018
Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium ReportJason M Elinoff, Richa Agarwal, Christopher F Barnett, et al.
Journal of the American College of Cardiology|July 24, 2024
Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary PreventionJingqin Wu, Corey Giles, Aleksandar Dakic, et al.
Circulation Research|October 28, 2017
PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through PhenomicsAnna R Hemnes, Gerald J Beck, John H Newman, et al.
Pageof 4